Ethyl 2-(triphenylphosphoranylidene)propionate

We are Ethyl 2-(triphenylphosphoranylidene)propionate CAS:5717-37-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  Ethyl 2-(triphenylphosphoranylidene)propionate
CAS.NO:   5717-37-3
Synonyms:ethyl 2-(triphenyl-λ<sup>5</sup>-phosphanylidene)propanoate

Molecular Formula: C23H23O2P
Molecular Weight:  362.40100

Physical and Chemical Properties:
Density: 1.14 g / cm3
Boiling point: 497.2ºC at 760 mmHg
Melting point: 158-162 ° C (lit.)
Flash point: 267.6ºC
Refractive index: 1.634

Specification:
Appearance: White  Powder
Purity: >99%
Moisture:<1.0%
Heavy Metals:<0.0005%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Storage:0°C-6°C.Stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Application:Intermediates of Omapatrilat CAS:167305-00-2.

 Ethyl 2-(triphenylphosphoranylidene)propionate


Related News: Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethanamine According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).7- (3-cloropropoxi) -6-metoxi-4-oxo-1,4-dihidro-3-quinolincarbon itrilo CAS:214470-66-3 In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.1003709-96-3 In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.

Related Products
Product Name
3-(triphenylen-2-yl)phenylboronic acid View Details
7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)-1H-quinolin-4-one View Details
3-(Trifluoromethyl)benzyl bromide View Details
3-bromo-1,2-difluoro-4-nitrobenzene manufacturer Boc-N-alpha-methyl-O-benzyl-L-tyrosine manufacturer L-Threonine manufacturer [3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide manufacturer 4-(4-bromophenyl)dibenzofuran manufacturer